Persistence and remission of ADHD during adulthood: A 7-year clinical follow-up study

Psychological Medicine

Volumn 45, Issue 10, 2015, Pages 2045-2056

  Karam, R G ^a,b   Breda, V ^a,b   Picon, F A ^a,b,c   Rovaris, D L ^a,b   Victor, M M ^a,b   Salgado, C A I ^a,b   Vitola, E S ^a,b   Silva, K L ^a,b   Guimaraes Da Silva P O ^a,b   Mota, N R ^a,b   Caye, A ^a   Belmonte De Abreu, P ^a,b   Rohde, L A ^a,b,c   Grevet, E H ^a,b   Bau, C H D ^a,b  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c National Institute of Developmental Psychiatry for Children and Adolescents (INPD/Brazil)   (Brazil)

Author keywords

Adults; attention; co morbidity; diagnosis; hyperactivity; longitudinal study; predictors; prospective

Indexed keywords

CENTRAL STIMULANT AGENT; METHYLPHENIDATE;

ADOLESCENT; ADULT; AGED; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAZIL; COMORBIDITY; COMPLICATION; FOLLOW UP; HUMAN; MIDDLE AGED; PSYCHOLOGICAL INTERVIEW; PSYCHOLOGY; REGRESSION ANALYSIS; REMISSION; SOCIAL PHOBIA; TEACHING HOSPITAL; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAZIL; CENTRAL NERVOUS SYSTEM STIMULANTS; COMORBIDITY; FOLLOW-UP STUDIES; HOSPITALS, TEACHING; HUMANS; INTERVIEW, PSYCHOLOGICAL; METHYLPHENIDATE; MIDDLE AGED; PHOBIA, SOCIAL; REGRESSION ANALYSIS; REMISSION INDUCTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84930179017     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291714003183     Document Type: Article

References (51)

1. APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV). American Psychiatric Association: Washington, DC.
2. Barbaresi WJ, Colligan RC, Weaver AL, Voigt RG, Killian JM, Katusic SK (2013). Mortality, ADHD, and psychosocial adversity in adults with childhood ADHD: a prospective study. Pediatrics 131, 637-644.
3. Barkley RA, Murphy KR (1998). Attention-Deficit Hyperactivity Disorder, 2nd edn. Guilford Press: New York, NY.
4. Barkley RA, Murphy KR, Fischer M (2008). ADHD in Adults: What the Science Says. Guilford Press: New York, NY.
5. Biederman J, Faraone SV (2004). The Massachusetts General Hospital studies of gender influences on attention-deficit/ hyperactivity disorder in youth and relatives. Psychiatric Clinics of North America 27, 225-232.
6. Biederman J, Mick E, Faraone SV (2000). Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. American Journal of Psychiatry 157, 816-818.
7. Biederman J, Petty CR, Clarke A, Lomedico A, Faraone SV (2011). Predictors of persistent ADHD: an 11-year follow-up study. Journal of Psychiatric Research 45, 150-155.
8. Castells X, Ramos-Quiroga JA, Rigau D, Bosch R, Nogueira M, Vidal X, Casas M (2011). Efficacy of methylphenidate for adults with attention-deficit hyperactivity disorder. CNS Drugs 25, 157-169.
9. Cloninger CR, Svrakic DM (1993). A psychobiological model of temperament and character. Archives of General Psychiatry 50, 975-990.
10. Cortese S, Imperati D, Zhou J, Proal E, Klein RG, Mannuzza S, Ramos-Olazagasti MA, Milham MP, Kelly C, Castellanos FX (2013). White matter alterations at 33-year follow-up in adults with childhood attention-deficit/ hyperactivity disorder. Biological Psychiatry 74, 591-598.
11. Cubillo A, Halari R, Smith A, Taylor E, Rubia K (2012). A review of fronto-striatal and fronto-cortical brain abnormalities in children and adults with Attention Deficit Hyperactivity Disorder (ADHD) and new evidence for dysfunction in adults with ADHD during motivation and attention. Cortex 48, 194-215.
12. Faraone SV, Biederman J, Mick E (2006). The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychological Medicine 36, 159-165.
13. First MB, Spitzer RL, Gibbon M, Williams J (1998). Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P, Version 2. 0, 8/98 revision). Biometrics Research Department, New York State Psychiatric Institute: New York, NY.
14. Gaub M, Carlson CL (1997). Gender differences in ADHD: a meta-analysis and critical review. Journal of the American Academy of Child and Adolescent Psychiatry 36, 1036-1045.
15. Grevet EH, Bau CH, Salgado CA, Fischer AG, Kalil K, Victor MM, Garcia CR, Sousa NO, Rohde LA, Belmonte-de-Abreu P (2006). Lack of gender effects on subtype outcomes in adults with attention-deficit/ hyperactivity disorder. European Archives of Psychiatry and Clinical Neuroscience 256, 311-319.
16. Grevet EH, Bau CH, Salgado CA, Fischer A, Victor MM, Garcia C, de Sousa NO, Nerung L, Belmonte-De-Abreu P (2005). Interrater reliability for diagnosis in adults of attention deficit hyperactivity disorder and oppositional defiant disorder using K-SADS-E. Arquivos de Neuro-Psiquiatria 63, 307-310.
17. Hart H, Radua J, Nakao T, Mataix-Cols D, Rubia K (2013). Meta-analysis of functional magnetic resonance imaging studies of inhibition and attention in attention-deficit/ hyperactivity disorder. JAMA Psychiatry 70, 185-198.
18. Hoekzema E, Carmona S, Ramos-Quiroga JA, Richarte Fernández V, Picado M, Bosch R, Soliva JC, Rovira M, Vives Y, Bulbena A, Tobeña A, Casas M, Vilarroya O (2012). Laminar thickness alterations in the fronto-parietal cortical mantle of patients with attention-deficit/hyperactivity disorder. PLoS ONE 7, e48286.
19. Kaplan E, Fein D, Morris R, Delis DC (1991). WAIS-R as a Neuropsychological Instrument, Manual. The Psychological Corporation: San Antonio, TX.
20. Karam RG, Bau CH, Salgado CA, Kalil KL, Victor MM, Sousa NO, Vitola ES, Picon FA, Zeni GD, Rohde LA, Belmonte-de-Abreu P, Grevet EH (2009). Late-onset ADHD in adults: milder, but still dysfunctional. Journal of Psychiatric Research 43, 697-701.
21. Kessler RC, Adler LA, Barkley R, Biederman J, Conners CK, Faraone SV, Greenhill LL, Jaeger S, Secnik K, Spencer T, Ustün TB, Zaslavsky AM (2005). Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biological Psychiatry 57, 1442-1451.
22. Kessler RC, Adler L, Barkley R, Biederman J, Conners CK, Demler O, Faraone SV, Greenhill LL, Howes MJ, Secnik K, Spencer T, Ustun TB, Walters EE, Zaslavsky AM (2006). The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. American Journal of Psychiatry 163, 716-723.
23. Kieling C, Kieling RR, Rohde LA, Frick PJ, Moffitt T, Nigg JT, Tannock R, Castellanos FX (2010). The age at onset of attention deficit hyperactivity disorder. American Journal of Psychiatry 167, 14-16.
24. Klein RG, Mannuzza S, Olazagasti MAR, Roizen E, Hutchison JA, Lashua EC, Castellanos FX (2012). Clinical and functional outcome of childhood attention-deficit/ hyperactivity disorder 33 years later. Archives of General Psychiatry 69, 1295-1303.
25. Lara C, Fayyad J, de Graaf R, Kessler RC, Aguilar-Gaxiola S, Angermeyer M, Demytteneare K, de Girolamo G, Haro JM, Jin R, Karam EG, Lépine JP, Mora ME, Ormel J, Posada-Villa J, Sampson N (2009). Childhood predictors of adult attention-deficit/hyperactivity disorder: results from the World Health Organization World Mental Health Survey Initiative. Biological Psychiatry 65, 46-54.
26. Mattos P, Palmini A, Salgado CA, Segenreich D, Grevet E, Oliveira IR, Rohde LA, Romano M, Louzã M, Belmonte de Abreu P, Lima PP (2006). Brazilian consensus of specialists on the diagnosis of attention-deficit/ hyperactivity disorder in adults. Revista de Psiquiatria do Rio Grande do Sul 28, 50-60.
27. Mannuzza S, Klein RG, Bessler A, Malloy P, LaPadula M (1998). Adult psychiatric status of hyperactive boys grown up. American Journal of Psychiatry 155, 493-498.
28. McGough JJ, Smalley SL, McCracken JT, Yang M, Del'Homme M, Lynn DE, Loo S (2005). Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. American Journal of Psychiatry 162, 1621-1627.
29. Mercadante MT, Asbahr F, Rosário MC, Ayres AM (1995). K-SADS, entrevista semi-estruturada para diagnóstico em psiquiatria da infância, versão epidemiológica. FMUSP: São Paulo, SP.
30. Monuteaux MC, Mick E, Faraone SV, Biederman J (2010). The influence of sex on the course and psychiatric correlates of ADHD from childhood to adolescence: a longitudinal study. Journal of Child Psychology and Psychiatry 51, 233-241.
31. Moriyama TS, Polanczyk GV, Terzi FS, Faria KM, Rohde LA (2013). Psychopharmacology and psychotherapy for the treatment of adults with ADHD-a systematic review of available meta-analyses. CNS Spectrums 18, 296-306.
32. Nakao T, Radua J, Rubia K, Mataix-Cols D (2011). Gray Matter volume abnormalities in ADHD: voxel-based meta-analysis exploring the effects of age and stimulant medication. American Journal of Psychiatry 168, 1154-1163.
33. Nutt DJ, Fone K, Asherson P, Bramble D (2007). Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 21, 10-41.
34. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA (2007). The worldwide prevalence of ADHD: a systematic review and metaregression analysis. American Journal of Psychiatry 164, 942-948.
35. Polanczyk G, Caspi A, Houts R, Kollins SH, Rohde LA, Moffitt TE (2010). Implications of extending the ADHD age-of-onset criterion to age 12: results from a prospectively studied birth cohort. Journal of the American Academy of Child and Adolescent Psychiatry 49, 210-216.
36. Ramtekkar UP, Reiersen AM, Todorov AA, Todd RD (2010). Sex and age differences in attention-deficit/hyperactivity disorder symptoms and diagnoses: implications for DSM-V and ICD-11. Journal of the American Academy of Child and Adolescent Psychiatry 49, 217-228.
37. Rasmussen P, Gillberg C (2000). Natural outcome of ADHD with developmental coordination disorder at age 22 years: a controlled, longitudinal, community-based study. Journal of the American Academy of Child and Adolescent Psychiatry 39, 1424-1431.
38. Riddle MA, Yershova K, Lazzaretto D, Paykina N, Yenokyan G, Greenhill L, Abikoff H, Vitiello B, Wigal T, McCracken JT, Kollins SH, Murray DW, Wigal S, Kastelic E, McGough JJ, dos Reis S, Bauzó-Rosario A, Stehli A, Posner K (2013). The preschool attention-deficit/ hyperactivity disorder treatment study (PATS) 6-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry 52, 264-278.
39. Rosellini AJ, Rutter LA, Bourgeois ML (2013). The relevance of age of onset to the psychopathology of social phobia. Journal of Psychopathology and Behavioral Assessment 35, 356-365.
40. Shaw P, Eckstrand K, Lerch JP, Greenstein D, Clasen L (2007). Attention-deficit/hyperactivity disorder is characterized by a delay in cortical maturation. Proceedings of the National Academy of Sciences 104, 19649-19654.
41. Shaw P, MalekM,Watson B, SharpW, Evans A, Greenstein D (2012). Development of cortical surface area and gyrification in attention-deficit/hyperactivity disorder. Biological Psychiatry 72, 191-197.
42. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998). The Mini-International Neuropsychiatric Interview (M. I. N. I. ): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry 59(Suppl. 20), 22-33.
43. Simon V, Czobor P, Bálint S, Mészáros A, Bitter I (2009). Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. British Journal of Psychiatry 194, 204-211.
44. Souery D, Oswald P, Massat I, Bailer U, Bollen J, Demyttenaere K, Kasper S, Lecrubier Y, Montgomery S, Serretti A, Zohar J, Mendlewicz J (2007). Group for the study of resistant depression: clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study. Journal of Clinical Psychiatry 68, 1062-1070.
45. Stringaris A, Goodman R (2009). Longitudinal outcome of youth oppositionality: irritable, headstrong, and hurtful behaviors have distinctive predictions. Journal of the American Academy of Child and Adolescent Psychiatry 48, 404-412.
46. Victor MM, Grevet EH, Salgado CA, Silva KL, Sousa NO, Karam RG, Vitola ES, Picon FA, Zeni GD, Contini V, Rohde LA, Belmonte-de-Abreu P, Bau CH (2009). Reasons for pretreatment attrition and dropout from methylphenidate in adults with attention-deficit/hyperactivity disorder: the role of comorbidities. Journal of Clinical Psychopharmacology 29, 614-616.
47. Victor MM, Rovaris DL, Salgado CA, Silva KL, Karam RG, Vitola ES, Picon FA, Contini V, Guimarães-da-Silva PO, Blaya-Rocha P, Belmonte-de-Abreu PS, Rohde LA, Grevet EH, Bau CH (2014). Severity but not comorbidities predicts response to methylphenidate in adults with attentiondeficit/ hyperactivity disorder: results from a naturalistic study. Journal of Clinical Psychopharmacology 34, 212-217.
48. Vitola ES, Salgado CA, Silva KL, Karam RG, Victor MM, Mota NR, Contini V, Picon FA, Guimarães-da-Silva PO, Giordani RS, Rohde LA, Belmonte-de-Abreu P, Bau CH, Grevet EH (2012). The role of a lifetime history of oppositional defiant and conduct disorders in adults with ADHD: implications for clinical practice. CNS Spectrums 17, 94-99.
49. Volkow ND, Swanson JM (2013). Clinical practice: adult attention deficit-hyperactivity disorder. New England Journal of Medicine 369, 1935-1944.
50. Wechsler D (1981). WAIS-R, Wechsler Adult Intelligence Scale-Revised, Manual. The Psychological Corporation: New York, NY.
51. Weiss G, Hechtman L, Milroy T, Perlman T (1985). Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. Journal of the American Academy of Child Psychiatry 24, 211-220.